Skip to main content

Table 3 Chronic effect of A. marmelos extract on HbA1c (A) and AGEs (B) in the diabetic rats

From: Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos

A.

 

HbA1c (%)

Groups

Day 1

Day 43

 Control (n = 11)

3.95 ± 0.10

4.06 ± 0.13

 Db (n = 8)

5.97 ± 0.12

11.92 ± 0.59

 AM (n = 6)

5.88 ± 0.07

8.20 ± 0.18***

 AG (n = 6)

6.01 ± 0.05

9.05 ± 0.35***

B.

 

AGEs (mg/ml)

Groups

Day 43

 Control (n = 11)

0.55 ± 0.06

 Db (n = 8)

1.18 ± 0.19

 AM (n = 6)

0.66 ± 0.05*

 AG (n = 6)

0.58 ± 0.10**

  1. All values were expressed as mean ± SEM. Control, non-diabetic control rats; Db, untreated diabetic rats; AM, A. marmelos-treated rats; AG, aminoguanidine-treated rats. n = number of rats in each group. *p < 0.05, **p < 0.01, ***p < 0.001, compared with Db values (one-way ANOVA with Dunnett’s multicomparison test)